| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 207 |
| 1 | ASPIRIN 325 MG | 201 |
| 2 | ASPIRIN 81 MG | 201 |
| 3 | ROSUVASTATIN | 143 |
| 4 | PANTOPRAZOLE | 136 |
| 5 | BISOPROLOL FUMARATE | 124 |
| 6 | CLOPIDOGREL | 115 |
| 7 | AMLODIPINE | 114 |
| 8 | METFORMIN | 90 |
| 9 | DOXAZOSIN MESYLATE | 89 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACIDUM SALICYLICUM | 2 | 0.6667 |
| 1 | LEVOTHYROXINUM | 1 | 0.0714 |
| 2 | LIGHT MINERAL OIL, WHITE PETROLATUM | 1 | 0.0312 |
| 3 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 1 | 0.0102 |
| 4 | TETANUS IMMUNE GLOBULIN (HUMAN) | 1 | 0.0092 |
| 5 | CEFOTETAN DISODIUM | 1 | 0.0089 |
| 6 | ERTUGLIFLOZIN AND SITAGLIPTIN | 1 | 0.0083 |
| 7 | LEVAMLODIPINE | 1 | 0.0080 |
| 8 | CEFOTETAN | 1 | 0.0075 |
| 9 | ESOMEPRAZOLE SODIUM | 12 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 237 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 207 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 193 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 146 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 127 |
| 5 | Proton Pump Inhibitor [EPC] | 124 |
| 6 | Calcium Channel Blocker [EPC] | 114 |
| 7 | beta-Adrenergic Blocker [EPC] | 110 |
| 8 | Loop Diuretic [EPC] | 93 |
| 9 | Corticosteroid [EPC] | 85 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 25 | 0.0363 |
| 1 | l-Thyroxine [EPC] | 1 | 0.0204 |
| 2 | Interleukin-6 Antagonist [EPC] | 2 | 0.0031 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 31 | 0.0024 |
| 4 | Provitamin D2 Compound [EPC] | 62 | 0.0021 |
| 5 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 32 | 0.0014 |
| 7 | Vitamin D3 Analog [EPC] | 27 | 0.0013 |
| 8 | PCSK9 Inhibitor [EPC] | 33 | 0.0013 |
| 9 | Polyene Antifungal [EPC] | 40 | 0.0010 |